{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:40:18Z","timestamp":1793385618843,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T00:00:00Z","timestamp":1344902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00198-012-2112-9","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T13:19:15Z","timestamp":1344863955000},"page":"1161-1168","source":"Crossref","is-referenced-by-count":115,"title":["The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study"],"prefix":"10.1007","volume":"24","author":[{"name":"CaMos Research Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L-A.","family":"Fraser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. D.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. E.","family":"Targownik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,14]]},"reference":[{"key":"2112_CR1","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/jbmr.95","volume":"25","author":"C Berger","year":"2010","unstructured":"Berger C, Goltzman D, Langsetmo L, Joseph L, Kreiger N, Tenenhouse A et al (2010) Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res 25:1948\u20131957","journal-title":"J Bone Miner Res"},{"key":"2112_CR2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00198-008-0743-7","volume":"20","author":"A Papaioannou","year":"2009","unstructured":"Papaioannou A, Kennedy CC, Ioannidis G, Sawka A, Hopman WM, Pickard L et al (2009) The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int 20:703\u2013714","journal-title":"Osteoporos Int"},{"key":"2112_CR3","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s001980170017","volume":"12","author":"JD Adachi","year":"2001","unstructured":"Adachi JD, Loannidis G, Berger C, Joseph L, Papaioannou A, Pickard L et al (2001) The influences of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int 12:903\u2013908","journal-title":"Osteoporos Int"},{"key":"2112_CR4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.2009.50","volume":"301","author":"D Bliuc","year":"2009","unstructured":"Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513\u2013521","journal-title":"JAMA"},{"key":"2112_CR5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11926-010-0097-y","volume":"12","author":"DJ Becker","year":"2010","unstructured":"Becker DJ, Kilgore ML, Morrisey MA (2010) The societal burden of osteoporosis. Curr Rheumatol Rep 12:186\u2013191","journal-title":"Curr Rheumatol Rep"},{"key":"2112_CR6","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP Staa Van","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993\u20131000","journal-title":"J Bone Miner Res"},{"key":"2112_CR7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archinte.167.2.188","volume":"167","author":"JB Richards","year":"2007","unstructured":"Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC et al (2007) Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167:188\u2013194","journal-title":"Arch Intern Med"},{"key":"2112_CR8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archneurol.2010.341","volume":"68","author":"N Jett\u00e9","year":"2011","unstructured":"Jett\u00e9 N, Lix LM, Metge CJ, Prior HJ, McChesney J, Leslie WD (2011) Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis. Arch Neurol 68:107\u2013112","journal-title":"Arch Neurol"},{"key":"2112_CR9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.amjmed.2010.02.028","volume":"123","author":"G Mazziotti","year":"2010","unstructured":"Mazziotti G, Canalis E, Giustina A (2010) Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med 123:877\u2013884","journal-title":"Am J Med"},{"key":"2112_CR10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2011.01.007","volume":"124","author":"EW Yu","year":"2011","unstructured":"Yu EW, Bauer SR, Bain PA, Bauer DC (2011) Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med 124:519\u2013526","journal-title":"Am J Med"},{"key":"2112_CR11","unstructured":"U.S. Food and Drug Administration (2011). FDA Drug Safety Communication. possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors. Accessed at http:\/\/www.fda.gov\/drugs\/drugsafety\/postmarketdrugsafetyinformationforpateintsandproviders\/ucm213206.htm on July 1, 2011."},{"issue":"Suppl 2","key":"2112_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ajg.2009.49","volume":"104","author":"JJ Heidelbaugh","year":"2009","unstructured":"Heidelbaugh JJ, Goldberg KL, Inadomi JM (2009) Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk. Am J Gastroenterol 104(Suppl 2):27\u201332","journal-title":"Am J Gastroenterol"},{"key":"2112_CR13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archinternmed.2010.64","volume":"170","author":"MH Katz","year":"2010","unstructured":"Katz MH (2010) Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users. Arch Intern Med 170:747\u2013748","journal-title":"Arch Intern Med"},{"key":"2112_CR14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archinternmed.2010.89","volume":"170","author":"MD Howell","year":"2010","unstructured":"Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M et al (2010) Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 170:784\u2013790","journal-title":"Arch Intern Med"},{"key":"2112_CR15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2009.11.019","volume":"56","author":"EJ Hoorn","year":"2010","unstructured":"Hoorn EJ, van der Hoek J, de Man RA, Kuipers EJ, Bolwerk C, Zietse R (2010) A case series of proton pump inhibitor-induced hypomagnesemia. Am J Kidney Dis 56:112\u2013116","journal-title":"Am J Kidney Dis"},{"key":"2112_CR16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4330\/wjc.v3.i5.153","volume":"3","author":"SL Lin","year":"2011","unstructured":"Lin SL, Chang HM, Liu CP, Chou LP, Chan JW (2011) Clinical evidence of interaction between clopidogrel and proton pump inhibitors. World J Cardiol 3:153\u2013164","journal-title":"World J Cardiol"},{"key":"2112_CR17","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10620-010-1560-3","volume":"56","author":"E Sheen","year":"2011","unstructured":"Sheen E, Triadafilopoulos G (2011) Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci 56:931\u2013950","journal-title":"Dig Dis Sci"},{"key":"2112_CR18","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1592\/phco.28.8.951","volume":"28","author":"JA Kaye","year":"2008","unstructured":"Kaye JA, Jick H (2008) Proton pump inhibitor use and risk of hip fractures in patients without major risk factors. Pharmacotherapy 28:951\u2013959","journal-title":"Pharmacotherapy"},{"key":"2112_CR19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/14740338.2011.586628","volume":"10","author":"LE Targownik","year":"2011","unstructured":"Targownik LE, Leslie WD (2011) The relationship among proton pump inhibitors, bone disease and fracture. Expert Opin Drug Saf 10:901\u2013912","journal-title":"Expert Opin Drug Saf"},{"key":"2112_CR20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1017\/S0714980800009934","volume":"18","author":"N Kreiger","year":"1999","unstructured":"Kreiger N, Tenenhouse A, Joseph L, Mackenzie T, Poliquin S, Brown JP et al (1999) The Canadian Multicentre Osteoporosis Study (CaMos): background, rationale, methods. Can J Aging 18:376\u2013387","journal-title":"Can J Aging"},{"key":"2112_CR21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s001980170112","volume":"12","author":"JA Kanis","year":"2001","unstructured":"Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417\u2013427","journal-title":"Osteoporos Int"},{"key":"2112_CR22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00198-007-0426-9","volume":"19","author":"L Bessette","year":"2008","unstructured":"Bessette L, Ste-Marie L-G, Jean S, Davison KS, Beaulieu M, Baranci M et al (2008) The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int 19:79\u201386","journal-title":"Osteoporos Int"},{"key":"2112_CR23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.publhealth.20.1.145","volume":"20","author":"LD Fisher","year":"1999","unstructured":"Fisher LD, Lin DY (1999) Time-dependent covariates in the cox proportional-hazards regression model. Annu Rev Public Health 20:145\u2013157","journal-title":"Annu Rev Public Health"},{"key":"2112_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00223-008-9188-4","volume":"84","author":"C Roux","year":"2009","unstructured":"Roux C, Briot K, Gossec L, Kolta S, Blenk T, Felsenberg D et al (2009) Increase in vertebral fracture risk in postmenopausal women using omeprazole. Calcif Tissue Int 84:13\u201319","journal-title":"Calcif Tissue Int"},{"key":"2112_CR25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2125.2004.02078.x","volume":"57","author":"EE Roughead","year":"2004","unstructured":"Roughead EE, McGeechan K, Sayer GP (2004) Bisphosphonate use and subsequent prescription of acid suppressants. Br J Clin Pharmacol 57:813\u2013816","journal-title":"Br J Clin Pharmacol"},{"key":"2112_CR26","first-page":"38","volume":"101","author":"B McGowan","year":"2008","unstructured":"McGowan B, Bennett K, Barry M, Canny M (2008) The utilisation and expenditure of medicines for the prophylaxis and treatment of osteoporosis. Ir Med J 101:38\u201341","journal-title":"Ir Med J"},{"issue":"3","key":"2112_CR27","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00198-010-1337-8","volume":"22","author":"S Pouwels","year":"2011","unstructured":"Pouwels S, Lalmohamed A, Souverein P, Cooper C, Veldt BJ, Leufkens HG et al (2011) Use of proton pump inhibitors and risk of hip\/femur fracture: a population-based case-control study. Osteoporos Int 22(3):903\u201310","journal-title":"Osteoporos Int"},{"key":"2112_CR28","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","volume":"296","author":"YX Yang","year":"2006","unstructured":"Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296:2947\u20132953","journal-title":"JAMA"},{"key":"2112_CR29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1503\/cmaj.071330","volume":"179","author":"LE Targownik","year":"2008","unstructured":"Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD (2008) Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ 179:319\u2013326","journal-title":"CMAJ"},{"key":"2112_CR30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-132-5-200003070-00003","volume":"132","author":"KE Ensrud","year":"2000","unstructured":"Ensrud KE, Duong T, Cauley JA, Heaney RP, Wolf RL, Harris E et al (2000) Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Ann Intern Med 132:345\u2013353","journal-title":"Ann Intern Med"},{"key":"2112_CR31","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1172\/JCI111254","volume":"73","author":"GW Bo-Linn","year":"1984","unstructured":"Bo-Linn GW, Davis GR, Buddrus DJ, Morawski SG, Santa Ana C, Fordtran JS (1984) An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium. J Clin Invest 73:640\u2013647","journal-title":"J Clin Invest"},{"key":"2112_CR32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/07315724.1995.10718522","volume":"14","author":"C Serfaty-Lacrosniere","year":"1995","unstructured":"Serfaty-Lacrosniere C, Wood RJ, Voytko D, Saltzman JR, Pedrosa M, Sepe TE et al (1995) Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. J Am Coll Nutr 14:364\u2013368","journal-title":"J Am Coll Nutr"},{"key":"2112_CR33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM198507113130202","volume":"313","author":"RR Recker","year":"1985","unstructured":"Recker RR (1985) Calcium absorption and achlorhydria. N Engl J Med 313:70\u201373","journal-title":"N Engl J Med"},{"key":"2112_CR34","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.amjmed.2005.02.007","volume":"118","author":"MB O'Connell","year":"2005","unstructured":"O'Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ (2005) Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med 118:778\u2013781","journal-title":"Am J Med"},{"key":"2112_CR35","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMoa032739","volume":"350","author":"RR McLean","year":"2004","unstructured":"McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE et al (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042\u20132049","journal-title":"N Engl J Med"},{"key":"2112_CR36","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/j.gastro.2009.11.014","volume":"138","author":"LE Targownik","year":"2010","unstructured":"Targownik LE, Lix LM, Leung S, Leslie WD (2010) Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. Gastroenterology 138:896\u2013904","journal-title":"Gastroenterology"},{"key":"2112_CR37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00223-008-9170-1","volume":"83","author":"EW Yu","year":"2008","unstructured":"Yu EW, Blackwell T, Ensrud KE, Hillier TA, Lane NE, Orwoll E et al (2008) Acid-suppressive medications and risk of bone loss and fracture in older adults. Calcif Tissue Int 83:251\u2013259","journal-title":"Calcif Tissue Int"},{"key":"2112_CR38","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archinternmed.2010.94","volume":"170","author":"SL Gray","year":"2010","unstructured":"Gray SL, LaCroix AZ, Larson J (2010) Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women\u2019s Health Initiative. Arch Intern Med 170:765\u2013771","journal-title":"Arch Intern Med"},{"key":"2112_CR39","doi-asserted-by":"crossref","unstructured":"Targownik LE, Leslie WD, Davison S, Goltzmen D, Jamal S, Josse RG, et al Proton pump inhibitors are associated with decreased bone mineral density. Amer J Gastroenterol. 106(Suppl 2):405.","DOI":"10.14309\/00000434-201110002-01089"},{"key":"2112_CR40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01352010","volume":"53","author":"K Mizunashi","year":"1993","unstructured":"Mizunashi K, Furukawa Y, Katano K, Abe K (1993) Effect of omeprazole, an inhibitor of H+, K(+)-ATPase, on bone resorption in humans. Calcif Tissue Int 53:21\u201325","journal-title":"Calcif Tissue Int"},{"key":"2112_CR41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/156720109787846225","volume":"6","author":"AR Sheraly","year":"2009","unstructured":"Sheraly AR, Lickorish D, Sarraf F, Davies JE (2009) Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo. Curr Drug Deliv 6:192\u2013198","journal-title":"Curr Drug Deliv"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2112-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-012-2112-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2112-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T14:29:38Z","timestamp":1594564178000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-012-2112-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,14]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["2112"],"URL":"https:\/\/doi.org\/10.1007\/s00198-012-2112-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,14]]}}}